Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion

Jin H Li1,2, Ying Tang3, Jun Lv3

  • 1Department of Nephrology, The Seventh Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China.

Insights

Macrophage migration inhibitory factor (MIF) drives acute kidney injury (AKI). Lowering MIF levels protected against kidney damage by reducing inflammation and improving outcomes in both patients and a mouse model.

Area of Science:

  • Immunology
  • Nephrology
  • Molecular Biology

Background:

  • Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine implicated in various inflammatory and immune diseases.
  • The specific role of MIF in acute kidney injury (AKI) has not been fully elucidated.
  • Understanding MIF's function in AKI is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of MIF in the pathogenesis of acute kidney injury (AKI).
  • To examine the correlation between MIF levels and AKI severity in clinical and experimental settings.
  • To explore the underlying molecular mechanisms by which MIF contributes to AKI.

Main Methods:

  • Clinical analysis of plasma and urinary MIF levels in AKI patients.
  • Experimental induction of kidney ischemic reperfusion injury (IRI) in wild-type (WT) and MIF knockout (KO) mice.
  • Assessment of renal inflammation markers, immune cell infiltration, and signaling pathways (CD74/TLR4-NF-κB).

Main Results:

  • Elevated plasma and urinary MIF levels in AKI patients correlated with serum creatinine and disease severity.
  • Mice lacking MIF (KO) showed suppressed renal inflammation, reduced tubular necrosis, and protected kidney function after IRI-AKI.
  • MIF deficiency attenuated the CD74/TLR4-NF-κB signaling pathway, decreasing pro-inflammatory cytokine expression and immune cell infiltration.

Conclusions:

  • MIF plays a pathogenic role in acute kidney injury.
  • Plasma and urinary MIF levels serve as potential biomarkers for AKI progression and resolution.
  • Targeting MIF or its signaling pathway may offer a therapeutic strategy for AKI.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
438
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.4K
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
522
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels01:31

Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels

Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
587
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K